(2022-05-28). Corea del Norte reporta menos 100 mil casos de coronavirus. telesurtv.net Desde finales de abril, Corea del Norte contabiliza 3.36 millones de contagios de la Covid-19.
(2022-05-28). [Perspectives] Impossible times. thelancet.com During the COVID-19 pandemic health-care workers have often found themselves in the media spotlight. The pandemic has been framed as a war, and health-care workers have been labelled as soldiers on the front line. But using a wartime narrative to depict the pandemic is dangerous "None of you think you are soldiers, dodging spinning bullets shaped like pretty viral crowns", asserts Roopa Farooki in her book Everything is True: A Junior Doctor's Story of Life, Death and Grief in a Time of Pandemic.
(2022-05-28). [Correspondence] Violence against health-care workers in the Philippines. thelancet.com Filipino health-care workers have not been immune to the growing violence and impunity in the country since President Duterte took office in 2016. Since 2017, at least ten doctors have been violently killed in various regions of the Philippines. Six were killed in 2017 alone.1 In 2020, Mary Rose Sancelan, a city health officer in Negros Oriental, and the only doctor serving in the province's COVID-19 pandemic response, was shot dead with her husband. She was previously red-tagged by a local anti-communist vigilante group.
(2022-05-28). [World Report] Calls for independent evaluation of ACT-A welcomed. thelancet.com Experts working with the Access to COVID-19 Tools Accelerator welcome the conclusions of a key report on pandemic preparedness. Ann Danaiya Usher reports.
(2022-05-28). [Comment] Risankizumab for Crohn's disease. thelancet.com In The Lancet, two new studies report randomised controlled trials of risankizumab for Crohn's disease.1,2 In the first, Geert D'Haens and colleagues share the findings of the ADVANCE and MOTIVATE phase 3 trials comparing the efficacy and safety of risankizumab with placebo in the induction period.1 The intention-to-treat population included 850 patients (390 [46%] women, 460 [54%] men; median age 37 ∑5 years [IQR 13 ∑3]) for ADVANCE and 569 patients (276 [49%] women, 293 [51%] men; median age 39 ∑6 years [13 ∑3]) for MOTIVATE in hospital academic medical centres, clinical research units, and priv…
(2022-05-28). [Articles] Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial. thelancet.com Subcutaneous risankizumab is a safe and efficacious treatment for maintenance of remission in patients with moderately to severely active Crohn's disease and offers a new therapeutic option for a broad range of patients by meeting endpoints that might change the future course of disease.
(2022-05-28). [World Report] Sandstorms hit Iraq, sending thousands to hospital. thelancet.com Doctors raise concern over whether they will have the resources to treat the thousands of patients with respiratory problems. Shawn Yuan reports from Baghdad.
(2022-05-28). [World Report] Pushing for polio eradication. thelancet.com As polio cases resurge in many parts of the world, an updated strategy to eradicate the disease begins. Sophie Cousins reports.
(2022-05-28). [Editorial] A hunger for action. thelancet.com The basic nutritional needs of children are at grave risk. Worldwide, more than 13 ∑6 million children under 5 years have severe acute malnutrition, a serious wasting condition associated with poverty and prolonged insufficient access to food. Severe acute malnutrition weakens children's immunity, resulting in repeated rounds of diarrhoea and other infections, such as measles and malaria, and accounts for a fifth of deaths in this age group. In an alert released on May 17, UNICEF warned that over 10 million of these children do not have access to ready-to-use therapeutic food (RUTF), considered the most effec…
(2022-05-28). [Articles] Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials. thelancet.com Risankizumab was effective and well tolerated as induction therapy in patients with moderately to severely active Crohn's disease.
(2022-05-28). [Perspectives] Why stories about illness matter. thelancet.com Plagues and contagious epidemics have long inspired writers, Sophocles, Boccaccio, Daniel Defoe, Mary Shelley, Albert Camus, and Orhan Pamuk among them. In the past decades, other diseases have found gifted chroniclers. Oncologist Siddhartha Mukherjee's bestselling The Emperor of All Maladies: A Biography of Cancer, for instance, won the Pulitzer Prize in 2011. Physicians and medical historians continue to add to the literature on diseases, ranging from anxiety to kidney failure to osteoporosis and more.